Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
Crossref DOI link: https://doi.org/10.1186/s40659-018-0180-9
Published Online: 2018-09-04
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Murray, Nigel P.
Text and Data Mining valid from 2018-09-04
Article History
Received: 21 March 2018
Accepted: 28 August 2018
First Online: 4 September 2018